Background: In the field of bone tissue engineering, there has been an increasing interest in
biomedical materials with both high angiogenic ability and osteogenic ability. Among various osteogenesis
materials, bioactive borosilicate and borate glass scaffolds possess suitable degradation rate
and mechanical strength, thus drawing many scholars’ interests and attention.
Objective: In this study, we fabricated bioactive glass scaffolds composed of borosilicate 2B6Sr using
the Template-Method and incorporated Dimethyloxalylglycine (DMOG), a small-molecule angiogenic
drug possessing good angiogenic ability, to improve bone regeneration.
Methods: The in-vitro studies showed that porous borosilicate bioactive glass scaffolds released slowly,
a steady amount of DMOG and stimulated the proliferation and osteogenic differentiation of human bone
marrow stromal cells hBMSCs.
Results: In-vivo studies showed that the borosilicate bioactive glass scaffolds could significantly promote
new bone formation and neovascularization in rats’ calvarial bone defects.
Conclusion: These results indicated that DMOG-incorporated bioactive glass scaffold is a successful
compound with excellent angiogenesis-osteogenesis ability, which has favorable clinical prospects.